EBITDA: Income before interest, taxes, depreciation and amortization.
Beam Therapeutics Inc. (BEAM) had EBITDA of $-416.41M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$63.52M |
|
$-376.74M |
|
-- |
|
$63.52M |
|
$479.09M |
|
$-415.57M |
|
$38.87M |
|
$-376.70M |
|
$-376.70M |
|
$-376.74M |
|
$-376.74M |
|
$-376.74M |
|
$-376.74M |
|
$-415.57M |
|
|
EBITDA |
$-416.41M |
82.31M |
|
82.31M |
|
$-4.58 |
|
$-4.58 |
|
| Balance Sheet Financials | |
$878.15M |
|
$111.41M |
|
$225.68M |
|
$1.10B |
|
$182.07M |
|
-- |
|
$188.21M |
|
$370.28M |
|
$733.54M |
|
$733.54M |
|
$733.54M |
|
83.63M |
|
| Cash Flow Statement Financials | |
$-347.25M |
|
$185.01M |
|
$7.74M |
|
$444.61M |
|
$290.11M |
|
$-154.50M |
|
$120.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.82 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-654.25% |
|
-654.25% |
|
-655.57% |
|
-593.06% |
|
-593.13% |
|
$-356.19M |
|
-- |
|
-- |
|
-- |
|
0.06 |
|
-- |
|
-- |
|
-- |
|
-51.36% |
|
-51.36% |
|
-34.13% |
|
-51.36% |
|
$8.77 |
|
$-4.33 |
|
$-4.22 |
|